Longenesis 2nd best at EIT Health Catapult finals

Jun 21, 2023

Longenesis, a digital health start-up that offers a platform for biomedical organizations to accelerate clinical research, has won second place in the digital health category and a prize of €20,000 in the finals of the Catapult competition by the EIT Health – a Knowledge and Innovation Community of the European Institute of Innovation and Technology. Longenesis also received the AWS Special Award.

Catapult is one of the initiatives of the EIT Health, which provides health technology startups with access to training and mentoring, as well as networking opportunities. Competition for Catapult was fierce, with startups selected via several rounds. 

“This is a great platform for not only creating new partnerships and winning valuable prizes, but also telling a wider audience about our philosophy and solutions that enable healthcare institutions to go from being data donors to being co-creators of health data along with their patients,” says Emīls Sjundjukovs, co-founder and CEO of Longenesis.

Earlier this year, Longenesis also made it to the top 100 of the Entrepreneurship World Cup, having competed against 30,000 companies. 

In 2021, Longenesis took home the main prize from the Fifty Founders Battle pitch competition at the TechChill conference.

Source: Labs of Latvia

< Back to News




We re-affirm our commitment to the values that AmCham stands for and that we share.

Kārlis Danēvičs, Board member, Head of Credits and Risk at SEB Banka

We are very pleased to be part of AmCham and are looking forward to driving innovation forward in Latvia.

Mikko Fernström, General Manager, Biogen Latvia